If I could just make a comment, unfortunately, the genetic testing only identifies 50% of women at high risk, and the majority of women do not have any risk factors that would tell them they're at high risk. They wouldn't carry the genetic mutation, but they would still get breast cancer.
Risk assessment is what we're recommending, starting at age 25 to 30, as a way to demonstrate when they should start screening. I think that is really an essential component that we should be recommending, and this guideline did not address that.
Thank you.